Cover Image
Market Research Report

North America Cannabis Testing Market Forecast 2019-2027

Published by Inkwood Research Product code 556992
Published Content info 125 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Cannabis Testing Market Forecast 2019-2027
Published: May 13, 2019 Content info: 125 Pages
Description

KEY FINDINGS

Cannabis testing is majorly carried out to detect the presence of heavy metals, impurities, residual solvents, pesticides or chemicals in order to assure the safety of cannabis for medicinal use. The North American cannabis testing market is expected to grow at a healthy CAGR of 10.85% over the forecast years of 2019-2027.

MARKET INSIGHTS

The presence of major industry players such as Restec Corporation and Thermo Fisher Inc. is hugely responsible for driving the market growth in this region. Also, the increasing use of cannabis testing in the medical research and treatment due to its legalization in over 25 US states has hugely contributed to the market expansion. The market segments include by testing method, end-users, cannabis type, and product & software segments. The cannabis testing market has evolved rapidly in the global scenario. The cannabis testing involves several drug testing methods which include the utility of cannabis considering medical prescription, norms & policies (Law) and medicines related to sports.

COMPETITIVE INSIGHTS

Eli Lilly, Shimadzu Corporation, AB Sciex LLC, Accelerated Technology Laboratories, Inc., Thermo Fisher Scientific, Inc., CannaSafe Analytics, SDpharma Labs LLC (PharmLabs™ LLC), Cannabilab, Steep Hill Halent Laboratories, Inc., Test Lab Amsterdam, Restek Corporation, Pharmalab, Urofins Proxy Laboratories, SC Laboratories, Inc., PerkinElmer, Inc., LabLynx, Inc., Sigma-Aldrich (Acquired By Merck Group), Digipath, Inc., Agilent Technologies, Inc., GenTech Scientific, Waters Corporation, and Anresco Laboratories are some of the noted market players in this region.

Table of Contents
Product Code: 7413

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. POTENCY IS THE MAJOR TESTING TYPE
    • 3.2.2. LABORATORIES ARE THE LARGEST CONTRIBUTOR TO CANNABIS TESTING MARKET
    • 3.2.3. INHALATION CANNABIS IS THE PROMINENT CANNABIS TYPE

4. MARKET DYNAMICS

  • 4.1. MARKET DEFINITION AND SCOPE
  • 4.2. MARKET DRIVERS
    • 4.2.1. RECOGNITION OF CANNABIS FOR MEDICAL AND THERAPEUTIC USE BY THE MEDICAL FRATERNITY
    • 4.2.2. RISE IN THE NUMBER OF TESTING FACILITIES
    • 4.2.3. INCREASING LEGALIZATION OF THE USE OF CANNABIS FOR MEDICINE AND RESEARCH
    • 4.2.4. RISING AWARENESS ABOUT CANNABIS BENEFITS AIDED BY A STRONG COMMUNITY SUPPORT
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. LACK OF UNIFORM INDUSTRY STANDARDS
    • 4.3.2. HIGH COSTS RELATED TO THE LABORATORY ANALYTICAL INSTRUMENTS USED FOR THE CANNABIS TESTING
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. INCREASING APPLICATIONS OF CANNABIS
    • 4.4.2. INCREASE IN VENTURE FUNDING FOR CANNABIS TESTING
  • 4.5. MARKET CHALLENGES
    • 4.5.1. SHORTAGE OF SKILLED PROFESSIONALS
    • 4.5.2. BLOCKAGES IN INITIAL SETUP
    • 4.5.3. PREJUDICES AGAINST THE USE OF CANNABIS

5. MARKET BY TYPE

    • 5.1.1. TERPENE PROFILING
    • 5.1.2. HEAVY METAL
    • 5.1.3. MICROBIAL ANALYSIS
    • 5.1.4. GENETIC
    • 5.1.5. RESIDUAL SOLVENT SCREENING
    • 5.1.6. POTENCY
    • 5.1.7. PESTICIDE SCREENING

6. MARKET BY PRODUCT & SOFTWARE

  • 6.1. PRODUCTS
    • 6.1.1. ANALYTICAL INSTRUMENTS
    • 6.1.2. CONSUMABLES
  • 6.2. SOFTWARE

7. MARKET BY END-USER

  • 7.1. LABORATORIES
  • 7.2. RESEARCH INSTITUTIONS

8. MARKET BY CANNABIS TYPE

  • 8.1. SOLID EDIBLE CANNABIS
  • 8.2. INHALING CANNABIS
  • 8.3. LIQUID EDIBLE CANNABIS
  • 8.4. TOPICAL CANNABIS
  • 8.5. OTHER CANNABIS TYPES

9. KEY ANALYTICS

  • 9.1. PORTER'S 5 FORCE MODEL
    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 9.1.3. BARGAINING POWER OF BUYER
    • 9.1.4. BARGAINING POWER OF SUPPLIER
    • 9.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 9.2. OPPORTUNITY MATRIX
  • 9.3. KEY BUYING CRITERIA
    • 9.3.1. COST
    • 9.3.2. REQUIREMENT
    • 9.3.3. EFFECTIVENESS
  • 9.4. VENDOR LANDSCAPE

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. UNITED STATES
    • 10.1.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. UNITED KINGDOM
    • 10.2.2. FRANCE
    • 10.2.3. GERMANY
    • 10.2.4. ITALY
    • 10.2.5. SPAIN
    • 10.2.6. REST OF EUROPE
  • 10.3. ASIA PACIFIC
    • 10.3.1. CHINA
    • 10.3.2. INDIA
    • 10.3.3. JAPAN
    • 10.3.4. SOUTH KOREA
    • 10.3.5. AUSTRALIA
    • 10.3.6. REST OF ASIA PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. LATIN AMERICA
    • 10.4.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. COMPANY PROFILE
    • 11.1.1. ACCELERATED TECHNOLOGY LABORATORIES, INC.
    • 11.1.2. AGILENT TECHNOLOGIES INC.
    • 11.1.3. ELI LILLY
    • 11.1.4. PERKINELMER, INC.
    • 11.1.5. ANRESCO LABORATORIES
    • 11.1.6. DIGIPATH, INC.
    • 11.1.7. STEEP HILL HALENT LABORATORIES, INC.
    • 11.1.8. SDPHARMA LABS LLC (PHARMLABS™ LLC)
    • 11.1.9. RESTEK CORPORATION
    • 11.1.10. SC LABORATORIES, INC.
    • 11.1.11. THERMO FISHER SCIENTIFIC, INC.
    • 11.1.12. SIGMA-ALDRICH (ACQUIRED BY MERCK GROUP)
    • 11.1.13. SHIMADZU CORPORATION
    • 11.1.14. WATERS CORPORATION
    • 11.1.15. AB SCIEX LLC
    • 11.1.16. CANNASAFE ANALYTICS
    • 11.1.17. LABLYNX, INC.
    • 11.1.18. GENTECH SCIENTIFIC
    • 11.1.19. CANNABILAB
    • 11.1.20. PHARMALAB
    • 11.1.21. UROFINS PROXY LABORATORIES
    • 11.1.22. TEST LAB AMSTERDAM

LIST OF TABLES

  • TABLE 1 NORTH AMERICA CANNABIS TESTING MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 2 NORTH AMERICA CANNABIS TESTING MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 3 NORTH AMERICA CANNABIS TESTING MARKET BY PRODUCT & SOFTWARE 2019-2027 ($ MILLION)
  • TABLE 4 NORTH AMERICA CANNABIS TESTING PRODUCTS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 5 NORTH AMERICA CANNABIS TESTING MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 6 NORTH AMERICA CANNABIS TESTING MARKET BY CANNABIS TYPE 2019-2027 ($ MILLION)
  • TABLE 7 NORTH AMERICA CANNABIS TESTING MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA CANNABIS TESTING MARKET, REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 2 NORTH AMERICA CANNABIS TESTING MARKET BY POTENCY TESTING 2019-2027 ($ MILLION)
  • FIGURE 3 NORTH AMERICA CANNABIS TESTING MARKET BY LABORATORIES 2019-2027 ($ MILLION)
  • FIGURE 4 NORTH AMERICA CANNABIS TESTING MARKET BY INHALING CANNABIS 2019-2027 ($ MILLION)
  • FIGURE 5 NORTH AMERICA CANNABIS TESTING MARKET BY TYPE 2018 & 2027 (%)
  • FIGURE 6 NORTH AMERICA CANNABIS TESTING MARKET BY TERPENE PROFILING 2019-2027 ($ MILLION)
  • FIGURE 7 NORTH AMERICA CANNABIS TESTING MARKET BY HEAVY METAL 2019-2027 ($ MILLION)
  • FIGURE 8 NORTH AMERICA CANNABIS TESTING MARKET BY MICROBIAL ANALYSIS 2019-2027 ($ MILLION)
  • FIGURE 9 NORTH AMERICA CANNABIS TESTING MARKET BY GENETIC TESTING 2019-2027 ($ MILLION)
  • FIGURE 10 NORTH AMERICA CANNABIS TESTING MARKET BY RESIDUAL SOLVENT SCREENING 2019-2027 ($ MILLION)
  • FIGURE 11 NORTH AMERICA CANNABIS TESTING MARKET BY POTENCY TESTING 2019-2027 ($ MILLION)
  • FIGURE 12 NORTH AMERICA CANNABIS TESTING MARKET BY PESTICIDE SCREENING 2019-2027 ($ MILLION)
  • FIGURE 13 NORTH AMERICA CANNABIS TESTING MARKET BY PRODUCT & SOFTWARE 2018 & 2027 (%)
  • FIGURE 14 NORTH AMERICA CANNABIS TESTING MARKET BY PRODUCT 2019-2027 ($ MILLION)
  • FIGURE 15 NORTH AMERICA CANNABIS TESTING PRODUCTS MARKET BY ANALYTICAL INSTRUMENTS 2019-2027 ($ MILLION)
  • FIGURE 16 NORTH AMERICA CANNABIS TESTING PRODUCTS MARKET BY CONSUMABLES 2019-2027 ($ MILLION)
  • FIGURE 17 NORTH AMERICA CANNABIS TESTING MARKET BY SOFTWARE 2019-2027 ($ MILLION)
  • FIGURE 18 NORTH AMERICA CANNABIS TESTING MARKET BY END-USER 2018 & 2027 (%)
  • FIGURE 19 NORTH AMERICA CANNABIS TESTING MARKET BY LABORATORIES 2019-2027 ($ MILLION)
  • FIGURE 20 NORTH AMERICA CANNABIS TESTING MARKET BY RESEARCH INSTITUTES 2019-2027 ($ MILLION)
  • FIGURE 21 NORTH AMERICA CANNABIS TESTING MARKET, BY CANNABIS TYPE 2018 & 2027 (%)
  • FIGURE 22 NORTH AMERICA CANNABIS TESTING MARKET BY SOLID EDIBLE 2019-2027 ($ MILLION)
  • FIGURE 23 NORTH AMERICA CANNABIS TESTING MARKET BY INHALING CANNABIS 2019-2027 ($ MILLION)
  • FIGURE 24 NORTH AMERICA CANNABIS TESTING MARKET BY LIQUID EDIBLE CANNABIS 2019-2027 ($ MILLION)
  • FIGURE 25 NORTH AMERICA CANNABIS TESTING MARKET BY TOPICAL CANNABIS 2019-2027 ($ MILLION)
  • FIGURE 26 NORTH AMERICA CANNABIS TESTING MARKET BY OTHER CANNABIS TYPES 2019-2027 ($ MILLION)
  • FIGURE 27 NORTH AMERICA CANNABIS TESTING MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 28 UNITED STATES CANNABIS TESTING MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 CANADA CANNABIS TESTING MARKET 2019-2027 ($ MILLION)
Back to Top